- 244
Ed Ruscha
Estimate
25,000 - 35,000 USD
Log in to view results
bidding is closed
Description
- Ed Ruscha
- Future
signed and dated 2012
- dry pigment and acrylic on museum-board paper
- 9 3/8 by 12 1/4 in. 23.8 by 31.1 cm.
- Executed in 2012, this work will be included in a forthcoming volume of Edward Ruscha: Catalogue Raisonné of the Works on Paper.
Provenance
Gift of the artist
Condition
This work appears in excellent condition overall. There is evidence of some extremely light handling along the extreme edges. Framed under Plexiglas.
In response to your inquiry, we are pleased to provide you with a general report of the condition of the property described above. Since we are not professional conservators or restorers, we urge you to consult with a restorer or conservator of your choice who will be better able to provide a detailed, professional report. Prospective buyers should inspect each lot to satisfy themselves as to condition and must understand that any statement made by Sotheby's is merely a subjective qualified opinion.
NOTWITHSTANDING THIS REPORT OR ANY DISCUSSIONS CONCERNING CONDITION OF A LOT, ALL LOTS ARE OFFERED AND SOLD "AS IS" IN ACCORDANCE WITH THE CONDITIONS OF SALE PRINTED IN THE CATALOGUE.
In response to your inquiry, we are pleased to provide you with a general report of the condition of the property described above. Since we are not professional conservators or restorers, we urge you to consult with a restorer or conservator of your choice who will be better able to provide a detailed, professional report. Prospective buyers should inspect each lot to satisfy themselves as to condition and must understand that any statement made by Sotheby's is merely a subjective qualified opinion.
NOTWITHSTANDING THIS REPORT OR ANY DISCUSSIONS CONCERNING CONDITION OF A LOT, ALL LOTS ARE OFFERED AND SOLD "AS IS" IN ACCORDANCE WITH THE CONDITIONS OF SALE PRINTED IN THE CATALOGUE.
Catalogue Note
Founded in 1998 by Co-Chairmen Leonard and Ronald Lauder, the ADDF's mission is to accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. 100% of funds raised by the ADDF is used to support Alzheimer's drug research and related programs. The ADDF has granted more than $51 million to fund 370 Alzheimer's drug discovery programs and clinical trials in academic centers and biotechnology companies in 18 countries.